Skip to menu Skip to content Skip to footer
Dr Monica Ng
Dr

Monica Ng

Email: 

Overview

Background

Dr Monica Ng is a staff specialist nephrologist and clinician scientist at Metro North Kidney Health Service where she leads the Research Portfolio, Translational Kidney Pathobiology Group and Clinical Trials Unit. Her other appointments includes Clinician Scientist at the Cardiac Drug Discovery laboratory and, Senior Lecturer and Clinical Theme Co-lead of Centre for Cardiovascular Health and Research at University of Queensland. Dr Ng's research seeks to improve information available for patient counselling, evaluate druggable targets for kidney disease and apply current-edge technologies (e.g. spatial transcriptomics, nanoparticle flow cytometry) for biomarker discovery in nephrology. These goals are achieved using a range of methodologies including registry data analysis, data linkage, extracellular vesicle analysis and cell culture, and clinical trial techniques.

Dr Ng contributes expertise to national and international steering committees as: Deputy Chair of the Australian and New Zealand Society of Nephrology Education and Training Committee, Asia-Pacific Co-Chair of the International Society of Extracellular Vesicles’ Genitourinary Special Interest Group, Member of Australasian Kidney Trials Network Chronic Kidney Disease-Glomerular Disease Working Group and Member of American Society of Nephrology's Editorial Board.

Availability

Dr Monica Ng is:
Available for supervision

Research interests

  • Extracellular vesicles as biomarkers of kidney disease

    Multi-omics assessment of extracellular vesicles from bio-fluids (e.g. blood, urine) as biomarkers for kidney disease.

  • Pathobiology of cardiovascular-kidney-metabolic syndrome

    Uncovering cardiac-kidney signaling mechanisms involved in the CKM syndrome.

  • Care after kidney transplant failure

    Analyzing large data to determine optimal immunosuppressive regimens after graft failure.

  • Kidney disease epidemiology

    Evaluating data from kidney failure registries and administrative databases to uncover risk factors for kidney disease incidence and outcomes. Assessing healthcare utilisation of people with kidney disease.

  • Novel therapies for kidney disease

    Evaluating novel kidney disease therapies in clinical trials.

Research impacts

Dr Ng's scientific contributions have improved information for patient counselling, discovered druggable targets and developed cutting-edge technologies (e.g. spatial transcriptomics, nanoparticle flow cytometry) for biomarker discovery in nephrology. She led the most comprehensive review of national and international kidney failure registries, providing granular variable-level information for health information system and inter-registry data planning (Kidney International, 3/91 nephrology journals). Dr Ng has demonstrated key signaling pathways perpetuating kidney injury, leading to highly cited publications (e.g. Redox Biology 2024; 70:103042 [citations 97th percentile], Cell Death & Disease 2022;13(8):739 [citations 91st percentile]). Her work developing extracellular vesicles into minimally-invasive tests for chronic kidney disease was presented in Discovery and Translational Award session at 2025 Australia and New Zealand Society of Nephrology Congress and published in Journal of Extracellular Vesicles (13/285 cell biology journals). Dr Ng is a Principal Investigator on numerous multi-centre clinical trials and an internationally-recognized expert on kidney disease management with invited publications in Nature Nephrology Reviews x2 and Kidney International x1; and invited presentations at international conferences (e.g. American Society of Nephrology Kidney Week 2025, International Society of Extracellular Vesicles Genitourinary System Extracellular Vesicles Special Interest Group Education Day 2024). Dr Ng's current research focuses on the interface between clinical and laboratory spheres to enable deep clinical, bimolecular and functional characterization of kidney disease for the discovery of novel biomarkers and druggable targets.

Works

Search Professor Monica Ng’s works on UQ eSpace

46 works between 2015 and 2026

41 - 46 of 46 works

2018

Journal Article

CFHR5 nephropathy in a Greek-Cypriot Australian family: ancestry-informed precision medicine

Ng, Monica S. Y., McClymont, Kelly, McCallum, Naomi, Dua, Rahul, Holman, Katherine, Bennetts, Bruce, Ho, Gladys, Patel, Chirag and Mallett, Andrew J. (2018). CFHR5 nephropathy in a Greek-Cypriot Australian family: ancestry-informed precision medicine. Kidney International Reports, 3 (5), 1222-1228. doi: 10.1016/j.ekir.2018.04.007

CFHR5 nephropathy in a Greek-Cypriot Australian family: ancestry-informed precision medicine

2018

Conference Publication

Validation of a web-based clinical decision support system to predict end-stage kidney disease in an Australian immunoglobin a nephropathy cohort

Ng, M. S., Harfield, M., Francis, L. and Mallett, A. J. (2018). Validation of a web-based clinical decision support system to predict end-stage kidney disease in an Australian immunoglobin a nephropathy cohort. 54th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Sydney, NSW, Australia, 8–12 September 2018. Richmond, VIC, Australia: John Wiley & Sons.

Validation of a web-based clinical decision support system to predict end-stage kidney disease in an Australian immunoglobin a nephropathy cohort

2018

Journal Article

Transfusion of packed red blood cells at the end of shelf life is associated with increased risk of mortality - a pooled patient data analysis of 16 observational trials

Ng, Monica S. Y., David, Michael, Middelburg, Rutger A., Ng, Angela S. Y., Suen, Jacky Y., Tung, John-Paul and Fraser, John F. (2018). Transfusion of packed red blood cells at the end of shelf life is associated with increased risk of mortality - a pooled patient data analysis of 16 observational trials. Haematologica, 103 (9), haematol.2018.191932-1548. doi: 10.3324/haematol.2018.191932

Transfusion of packed red blood cells at the end of shelf life is associated with increased risk of mortality - a pooled patient data analysis of 16 observational trials

2018

Journal Article

Platelet storage lesions: what more do we know now?

Ng, Monica Suet Ying, Tung, John-Paul and Fraser, John Francis (2018). Platelet storage lesions: what more do we know now?. Transfusion Medicine Reviews, 32 (3), 144-154. doi: 10.1016/j.tmrv.2018.04.001

Platelet storage lesions: what more do we know now?

2018

Conference Publication

Micro proteomic profiling in the diagnosis of kidney disease

Raghubar, A., Wang, X., Kassianos, A. J., Ng, M. S., Dave, K. A., Norris, E., Headlam, M. J., Healy, H. G. and Mallett, A. J. (2018). Micro proteomic profiling in the diagnosis of kidney disease. 54th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Sydney, Australia, 8–12 September 2018. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.13441

Micro proteomic profiling in the diagnosis of kidney disease

2015

Journal Article

Effects of packed red blood cell storage duration on post-transfusion clinical outcomes: a meta-analysis and systematic review

Ng, Monica Suet Ying, Ng, Angela Suet Yeung, Chan, Jessica, Tung, John-Paul and Fraser, John Francis (2015). Effects of packed red blood cell storage duration on post-transfusion clinical outcomes: a meta-analysis and systematic review. Intensive Care Medicine, 41 (12), 2087-2097. doi: 10.1007/s00134-015-4078-5

Effects of packed red blood cell storage duration on post-transfusion clinical outcomes: a meta-analysis and systematic review

Funding

Past funding

  • 2020 - 2022
    A multifaceted screen for personalized precision medicine targets for glomerulonephritides - from genotype to international big data analyses
    Metro North Hospital and Health Service
    Open grant
  • 2020 - 2021
    Applying Spatial Transcriptomics to Discover Kidney Disease Pathways and Optimize Clinical Kidney Biopsy Assessment
    Metro North Hospital and Health Service
    Open grant

Supervision

Availability

Dr Monica Ng is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Available projects

  • Hidden costs of kidney disease

    Characterising and quantifying impact of kidney disease on quality of life

  • Urine extracellular vesicles as novel biomarkers for kidney health and disease

    Wet laboratory and bioinformatics projects available. Multi-omics approaches with proteomics and RNA sequencing to identify novel biomarkers associating with kidney disease outcomes.

  • Role of extracellular vesicles in kidney disease

    Wet laboratory study using cellular models of kidney disease to study role of extracellular vesicle cargoes in kidney injury.

  • Novel biomarkers for cardiovascular-kidney-metabolic disease

    Multi-omics analysis to identify molecular markers for cardiovascular-kidney-metabolic disease ontology and outcomes.

  • Data yield from kidney biopsy

    Data analysis project evaluating data from kidney biopsies and clinical outcomes

Supervision history

Current supervision

  • Doctor Philosophy

    Leveraging complex cellular models and extracellular vesicles to reveal novel druggable targets in polycystic kidney disease

    Principal Advisor

    Other advisors: Dr Andrew Kassianos

Media

Enquiries

For media enquiries about Dr Monica Ng's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au